Knobbe Martens Delivers Federal Circuit Win for Lupin in Hatch-Waxman Dispute Involving Kidney Disease Drug
WASHINGTON, D.C., May 21, 2026 – A team from Knobbe Martens secured a substantial appellate victory on behalf of Lupin Ltd., ensuring patients a cost-effective option for treating life-threatening kidney...
Knobbe Martens, Dozens of Partners Receive Top Rankings in IP Law in Legal 500 USA Guide
IRVINE, Calif., June 11, 2026 – Knobbe Martens, a leading intellectual property law firm, is proud to share that the firm and three dozen lawyers received national and regional recognition...
Knobbe Martens Practices, Partners Recognized for Standout IP Work in 2026 Chambers USA Guide
IRVINE, Calif., June 4, 2026 – Knobbe Martens is proud to share that numerous practices and partners across the firm are recommended for exceptional work in the 2026 Chambers USA...